“Assessment of YME1L and mitofusin2 as a possible diagnostic and/or therapeutic target in hepatocellular carcinoma” (2023) Indian Journal of Biochemistry and Biophysics (IJBB), 60(1), pp. 43–54. doi:10.56042/ijbb.v60i1.62503.